Almirall

Almirall

Fabricación de productos farmacéuticos

Feel the Science

Sobre nosotros

Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).

Sitio web
http://www.almirall.com
Sector
Fabricación de productos farmacéuticos
Tamaño de la empresa
De 1.001 a 5.000 empleados
Sede
Barcelona
Tipo
Empresa pública
Fundación
1944
Especialidades
Dermatology (Actinic keratosis, Atopic Dermatitis, Eczema, Inflammatory Skin Conditions, Psoriasis, Rosacea, Severe Acne), OTC Products, Other Specialty Areas (e.g. Spasticity in Multiple Sclerosis) y Medical Device

Ubicaciones

  • Principal

    Ronda General Mitre, 151

    Barcelona, 08022, ES

    Cómo llegar
  • Carretera Laureà Miró, 408

    Sant Feliu de Llobregat, Barcelona 08980, ES

    Cómo llegar
  • Carretera de Martorell 41-61

    Sant Andreu de la Barca, Barcelona 08740 , ES

    Cómo llegar

Empleados en Almirall

Actualizaciones

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    🙌 Act4Impact: Our strategy for patients Our goal is to keep positively impacting people with skin conditions through our dermatology portfolio. This is a key strategic objective for our company. As part of our sustainability strategy, #Act4Impact 2030, we aim to enhance our engagement with patients, particularly focusing on the wellbeing of our dermatology patients. By fostering a patient-centric mindset throughout the company, we prioritize patients' needs and place them at the core of our decision-making process. Together, we can make a significant and lasting difference to society. #Act4Impact #Patients #TogetherWeCare

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    Today, we announced our strong first-half financial results, reinforcing our commitment to achieving our ambition as a leader in medical dermatology. The results of the European Dermatology business, which combine the growth of our biologics products with the continued strength of our broad dermatology portfolio, have driven our solid H1 performance. We are therefore pleased to confirm our guidance for 2024. For more information, visit www.almirall.com/media #WeAreAlmirall

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    ☀️ Our Headquarters is right on track to become our first carbon-neutral building.     Since early 2023, we have undertaken a major project to eliminate its carbon footprint and enhance energy efficiency. Key changes include replacing all natural gas usage, resulting in our consumption being entirely electric and sourced from renewables. Together, we are making a greater impact, leaving a sustainable footprint, and advancing our Net-Zero Strategy.     Watch the video for a detailed look at the project!   #Act4Impact #NetZero 

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    🌍 Act4Impact: Our strategy for People Through our #Act4Impact strategy, we are dedicated to fostering an inclusive and empowering environment for our employees. Our initiatives include implementing a Global Diversity, Equity, and Inclusion Plan, enhancing our Talent Management to unleash our employees' full potential, deploying our corporate holistic wellbeing program, and consolidating a corporate volunteering program. By investing in our people, we aim to create a workplace where everyone can thrive and contribute to our mission. Join us in acting for greater impact by supporting and empowering our diverse and talented team! #Act4Impact #WeAreAlmirall #TogetherWeCare

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    🙌The commitment of our employees drives our growth every day. This year, we are delighted to announce the winners of our Purpose Awards! Let's salute the exceptional teams who uphold Almirall's purpose and play a crucial role in helping us achieve our core mission of transforming patients' lives. This award celebrates the contributions of our teams in having the patient community in mind and embodies the essence of why we do what we do. Congratulations, teams! #ValuesAwards#WeAreAlmirall Lisa Werbeck Annette MÜLLER Cordula Seydel Sebastian Diemert Jordi Tugas Barrero Irene del Pozo Fàbregas Oscar Laseca

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    🌍 #Act4Impact: Our strategy for a sustainable planet As part of our Act4Impact sustainability strategy, we are committed to taking bold climate action through our science-led Net Zero Emissions Strategy. This initiative drives our efforts in energy decarbonization, promotes sustainable mobility, and advances our sustainable procurement plans. We also advocate actions towards water stewardship, circular economy, and nature protection. By caring for our planet, we aim to ensure a healthier and more sustainable future for everyone. Join us on this journey towards a meaningful and lasting difference in society and the environment! #Act4Impact #Sustainability #WeAreAlmirall

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    #News for #Media and #Investors: Today, we announced that our new product for the treatment of atopic dermatitis has been recommended by NICE (National Institute for Health and Care Excellence) and will be available for prescription where eligibility criteria are met. This regulatory milestone highlights our commitment to medical dermatology and is a further step in our purpose to improve the lives of people with atopic dermatitis. This is news for the media and investor community. Find out more in https://lnkd.in/dAkstqn

    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    New medical solutions and the expansion of existing products in several markets drive our growth trajectory in medical dermatology. In addition, our recent acquisitions strengthen our portfolio, positioning us to continue addressing unmet needs. As explained by our Chief Commercial Officer Europe & International, Paolo Cionini, our current treatments have experienced sustained growth and increased sales throughout 2023, as we prepare for forthcoming product launches. With a dedicated team and our focus on our ambition, we are poised to take the lead in the market and enhance the quality of life for countless patients. 📌Check the video below with Lidia Martín and Dirk Menschig to learn more about our business performance and visit our #YearInReview for more information as well as the full video https://lnkd.in/dfbCjQUc #YearInReview #WeAreAlmirall 

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    🌍 Sustainability is a core pillar of our long-term vision and company ambition. Today, we are proud to present #Act4Impact, our new 2030 Sustainability Strategy designed to enhance our positive impact on society and transform the lives of patients. Built on four strategic pillars—Planet, People, Patients, and Partners—our strategy is guided by principles of ethical conduct, transparency, and integrity. Aligned with the United Nations Sustainable Development Goals (SDGs) for 2030, Act4Impact ensures we continue to innovate, empower our teams, and collaborate for greater impact. Join us on this journey to a healthier, more sustainable world. Together, we can make a lasting impact on our planet and society! #WeAreAlmirall #Act4Impact

  • Ver la página de empresa de Almirall, gráfico

    125.421 seguidores

    Last week, we actively participated in the 7th World Psoriasis & Psoriatic Arthritis Conference of the IFPA, which took place from June 27 to 29 in Stockholm, Sweden, and focused on uncovering the broad spectrum of psoriatic disease. During this event, we unveiled new advancements in our ongoing commitment to improving the lives of people living with psoriasis and engaged in insightful conversations with the dermatology and patient community, fostering collaboration and innovation. As a company whose purpose is to improve people's lives, we recognize the importance of sharing valuable insights with patients and the dermatology community. By addressing real-world needs, we collectively pave the way for a brighter future. ✨ Let’s continue shedding light on psoriasis and working together to make a meaningful impact. #IFPAConference2024 #SheddingLightOnPsoriasis #Psoriasis

    • No hay descripción de texto alternativo para esta imagen

Páginas similares

Buscar empleos

Financiación

Almirall 1 ronda en total

Última ronda

Equidad tras OPV

215.792.796,00 US$

Ver más información en Crunchbase